Short Interest in Movano Inc. (NASDAQ:MOVE) Rises By 138.4%

Movano Inc. (NASDAQ:MOVE) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 91,584 shares, an increase of 138.4% from the June 30th total of 38,417 shares. Approximately 0.4% of the company’s stock are sold short. Based on an average daily trading volume, of 47,166 shares, the days-to-cover ratio is presently 1.9 days.

Institutional Investors Weigh In On Movano

A hedge fund recently bought a new position in Movano stock. Citadel Advisors LLC bought a new stake in shares of Movano Inc. (NASDAQ:MOVE) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano as of its most recent SEC filing. Institutional investors and hedge funds own 16.64% of the company’s stock.

More Movano News

Here are the key news stories impacting Movano this week:

• Positive Sentiment: No new negative operational development involving Movano was reported in the supplied articles, so the current weakness appears largely unrelated to a fresh company announcement.
• Neutral Sentiment: Trading volume in MOVE was well below its typical average, suggesting that the decline may reflect limited liquidity rather than strong, company-specific selling pressure.
• Negative Sentiment: U.S. stocks moved sharply lower as crude oil prices surged more than 7%, creating a risk-off environment that can weigh disproportionately on smaller, unprofitable technology and healthcare companies such as Movano. U.S. Stocks Move Sharply Lower As Crude Oil Prices Soar
• Negative Sentiment: Concerns that tighter monetary policy could trigger a broader market correction are also unfavorable for speculative growth stocks, which depend heavily on future financing and earnings potential. Stock Market Investors Just Got Bad News About President Trump’s Economy
• Negative Sentiment: Movano’s existing fundamentals remain a headwind: its latest reported quarter produced a larger-than-expected loss and revenue far below analyst estimates. The stock is also trading below its 50-day and 200-day moving averages, indicating weak technical momentum.

Movano Stock Down 3.0%

Shares of MOVE traded down $0.33 during midday trading on Wednesday, reaching $10.80. 28,278 shares of the stock were exchanged, compared to its average volume of 619,548. Movano has a 12-month low of $3.44 and a 12-month high of $26.72. The firm has a 50 day simple moving average of $18.64 and a 200-day simple moving average of $15.39. The company has a quick ratio of 2.04, a current ratio of 2.14 and a debt-to-equity ratio of 4.28. The company has a market cap of $298.51 million, a price-to-earnings ratio of -0.79 and a beta of 0.83.

Movano (NASDAQ:MOVE) last released its quarterly earnings data on Tuesday, May 19th. The technology company reported ($3.13) EPS for the quarter, missing analysts’ consensus estimates of ($2.65) by ($0.48). The company had revenue of $0.51 million during the quarter, compared to analysts’ expectations of $7.62 million.

Analysts Set New Price Targets

Separately, Wall Street Zen raised shares of Movano from a “sell” rating to a “hold” rating in a research note on Sunday, May 24th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.